Sivik Global Healthcare LLC Abb Vie Inc. Transaction History

Sivik Global Healthcare LLC

$236 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	BUY	$144.61 - $166.54 $5.78 Million - $6.66 Million	40,000 New	40,000 $6.38 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $2.75 Million - $3.5 Million	-20,000 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $2.64 Million - $3.28 Million	-20,000 Reduced 50.0%	20,000 $3.24 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $4.3 Million - $5.44 Million	40,000 New	40,000 $5.42 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $2.13 Million - $2.42 Million	-20,000 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $2.1 Million - $2.34 Million	20,000 New	20,000 $2.25 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $1.12 Million - $1.31 Million	-13,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $220,110 - $294,540	3,000 Added 30.0%	13,000 $5.87 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $2.58 Million - $3.91 Million	-40,000 Reduced 80.0%	10,000 $3.51 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $3.61 Million - $4.51 Million	50,000 New	50,000 $4.43 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $2.79 Million - $3.57 Million	-42,500 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$77.14 - $90.79 $3.28 Million - $3.86 Million	42,500 New	42,500 $3.43 Million
Q2 2018 Aug 06, 2018	SELL	$89.78 - $106.23 $6.73 Million - $7.97 Million	-75,000 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$92.01 - $123.21 $920,100 - $1.23 Million	10,000 Added 15.38%	75,000 $7.1 Million
Q4 2017 Feb 08, 2018	SELL	$89.56 - $98.21 $2.69 Million - $2.95 Million	-30,000 Reduced 31.58%	65,000 $6.29 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $6.64 Million - $8.48 Million	95,000	95,000 $8.44 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.

Account